These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 16368284

  • 1. The effects of oral anticoagulants in patients with peripheral arterial disease: rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials.
    WAVE Investigators.
    Am Heart J; 2006 Jan; 151(1):1-9. PubMed ID: 16368284
    [Abstract] [Full Text] [Related]

  • 2. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease.
    Mehta SR, Yusuf S, Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study Investigators.
    Eur Heart J; 2000 Dec; 21(24):2033-41. PubMed ID: 11102254
    [Abstract] [Full Text] [Related]

  • 3. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.
    Warfarin Antiplatelet Vascular Evaluation Trial InvestigatorsMcMaster University, Hamilton, ON, Canada. anands@mcmaster.ca, Anand S, Yusuf S, Xie C, Pogue J, Eikelboom J, Budaj A, Sussex B, Liu L, Guzman R, Cina C, Crowell R, Keltai M, Gosselin G.
    N Engl J Med; 2007 Jul 19; 357(3):217-27. PubMed ID: 17634457
    [Abstract] [Full Text] [Related]

  • 4. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial.
    Bhatt DL, Flather MD, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Fabry-Ribaudo L, Hu T, Topol EJ, Fox KA, CHARISMA Investigators.
    J Am Coll Cardiol; 2007 May 15; 49(19):1982-8. PubMed ID: 17498584
    [Abstract] [Full Text] [Related]

  • 5. Patients with peripheral arterial disease in the CHARISMA trial.
    Cacoub PP, Bhatt DL, Steg PG, Topol EJ, Creager MA, CHARISMA Investigators.
    Eur Heart J; 2009 Jan 15; 30(2):192-201. PubMed ID: 19136484
    [Abstract] [Full Text] [Related]

  • 6. Long-term effect of chronic oral anticoagulation with warfarin after acute myocardial infarction.
    Haq SA, Heitner JF, Sacchi TJ, Brener SJ.
    Am J Med; 2010 Mar 15; 123(3):250-8. PubMed ID: 20193834
    [Abstract] [Full Text] [Related]

  • 7. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range.
    Connolly SJ, Pogue J, Eikelboom J, Flaker G, Commerford P, Franzosi MG, Healey JS, Yusuf S, ACTIVE W Investigators.
    Circulation; 2008 Nov 11; 118(20):2029-37. PubMed ID: 18955670
    [Abstract] [Full Text] [Related]

  • 8. Effects of aspirin or picotamide, an antithromboxane agent, in combination with low-intensity oral anticoagulation in patients with acute myocardial infarction: a controlled randomized pilot trial.
    Vetrano A, Milani M, Corsini G.
    G Ital Cardiol; 1999 May 11; 29(5):524-8. PubMed ID: 10367219
    [Abstract] [Full Text] [Related]

  • 9. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H, Cohen M, Ezekowitz MD.
    J Invasive Cardiol; 2004 May 11; 16(5):271-8. PubMed ID: 15152137
    [Abstract] [Full Text] [Related]

  • 10. Oral anticoagulant therapy in patients with peripheral artery disease.
    Visseren FL, Eikelboom BC.
    Semin Vasc Med; 2003 Aug 11; 3(3):339-44. PubMed ID: 15199468
    [Abstract] [Full Text] [Related]

  • 11. Meta-analysis of the combination of warfarin and dual antiplatelet therapy after coronary stenting in patients with indications for chronic oral anticoagulation.
    Gao F, Zhou YJ, Wang ZJ, Yang SW, Nie B, Liu XL, Jia de A, Yan ZX.
    Int J Cardiol; 2011 Apr 01; 148(1):96-101. PubMed ID: 21185095
    [Abstract] [Full Text] [Related]

  • 12. An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial.
    Wang TH, Bhatt DL, Fox KA, Steinhubl SR, Brennan DM, Hacke W, Mak KH, Pearson TA, Boden WE, Steg PG, Flather MD, Montalescot G, Topol EJ, CHARISMA Investigators.
    Eur Heart J; 2007 Sep 01; 28(18):2200-7. PubMed ID: 17673448
    [Abstract] [Full Text] [Related]

  • 13. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
    Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, Connolly SJ, ACTIVE W Investigators.
    J Am Coll Cardiol; 2007 Nov 27; 50(22):2156-61. PubMed ID: 18036454
    [Abstract] [Full Text] [Related]

  • 14. Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation.
    Sarafoff N, Ndrepepa G, Mehilli J, Dörrler K, Schulz S, Iijima R, Byrne R, Schömig A, Kastrati A.
    J Intern Med; 2008 Nov 27; 264(5):472-80. PubMed ID: 18624903
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials.
    Saw J, Bhatt DL, Moliterno DJ, Brener SJ, Steinhubl SR, Lincoff AM, Tcheng JE, Harrington RA, Simoons M, Hu T, Sheikh MA, Kereiakes DJ, Topol EJ.
    J Am Coll Cardiol; 2006 Oct 17; 48(8):1567-72. PubMed ID: 17045889
    [Abstract] [Full Text] [Related]

  • 18. Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience.
    Maegdefessel L, Schlitt A, Faerber J, Bond SP, Messow CM, Buerke M, Raaz U, Werdan K, Muenzel T, Weiss C.
    Med Klin (Munich); 2008 Sep 15; 103(9):628-32. PubMed ID: 18813885
    [Abstract] [Full Text] [Related]

  • 19. Antiplatelet and antithrombotic treatment of patients with peripheral arterial disease.
    Poredos P, Jezovnik MK.
    Int Angiol; 2010 Feb 15; 29(1):20-6. PubMed ID: 20224527
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.